Moderna stocks: MRNA shares jump in US Stock market today after pharma giant surpasses Wall Street estimatesModerna had earlier posted a loss of $2.52 per share a year earlier, while analysts expected a loss of $3.96 per share.
Moderna says FDA will consider new flu shot after resolving public disputeThe FDA will now consider Moderna's mRNA flu vaccine application after a dispute over clinical trial design. Moderna agreed to seek full ap...
US FDA reverses course, will review Moderna's revised flu vaccine applicationThe US Food and Drug Administration will now review Moderna's influenza vaccine. This comes after an initial refusal due to trial design is...
RFK Jr. shocks big pharma, yanks $500 million from mRNA vaccine projects, including for Flu and COVIDUS Health Secretary Robert F. Kennedy Jr. stopped 22 vaccine projects. These projects used mRNA technology. The vaccines aimed to fight COV...
Emcure and its subsidiary Gennova settle legal dispute with HDT Bio over mRNA technologyEmcure Pharmaceuticals and its subsidiary Gennova have resolved all legal disputes with US-based HDT Bio Corp. The parties have entered int...
Novavax soars 146% on $1.2 billion Sanofi vaccine licensing dealThe pact links two big players in the vaccine world that both missed out on the rush to develop and commercialize Covid shots quickly durin...
China okays its first mRNA vaccine, from drugmaker CSPCChina, whose home-grown vaccines are seen as less effective than the Moderna and Pfizer-BioNTech mRNA shots, has been racing to develop vac...
The US keeps offering China its Covid vaccines. China keeps saying noWorried about the rise of new variants and impact on China’s economy, the US has repeatedly offered mRNA vaccines and other assistance to P...
Canadian scientists lead Nobel Prize medicine race for developing mRNA vaccineResearch has estimated that 19.8 million lives were saved by the vaccines in 2021.
Moderna sues Pfizer/BioNTech for patent infringement over COVID vaccineModerna alleges Pfizer/BioNTech, without permission, copied mRNA technology that Moderna had patented between 2010 and 2016, well before CO...
FDA flags heart issues after taking Novavax vaccineIn the company's nearly 30,000 patient trial, conducted between December 2020 and September 2021, there were four cases of myocarditis, a t...
Amid Covid vaccine success, BioNTech plans to return €2bn to shareholdersAfter the success of the covid vaccine, BioNTech is planning to return €2bn to shareholders. BioNTech will continue the clinical trial to b...
WHO works to spread COVID vaccine technology to more nationsAt a press briefing in Geneva on Wednesday, WHO Director-General Tedros Adhanom Ghebreyesus said the new hub will be in South Korea and wil...
Here’s why developing countries can make COVID-19 mRNA vaccinesDepending on wealthy nations to donate billions of doses is not working, public health experts say. The solution, many now believe, is for ...
Chinese firm buys Canada mRNA Covid vaccine tech in $500 million dealWhile almost 1 billion people have been fully vaccinated in China, the country is still lacking an mRNA shot, with most of the population i...
Vaccine tech transfer hard, next six months key in Covid fight, says leading vaccine makersOn Friday, senior executives from companies such as Moderna, GSK and Bharat Biotech addressed various issues on Covid vaccines, including e...
Moderna vaccine results 'stunningly impressive,' Fauci tells AFP"The idea that we have a 94.5 percent effective vaccine is stunningly impressive. It is really a spectacular result that I don't think anyb...